IDEAYA Biosciences, Inc. (IDYA)
40.11
-1.66
(-3.97%)
USD |
NASDAQ |
Aug 28, 16:00
40.11
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Total Liabilities (Quarterly) : 110.79M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 110.79M |
| March 31, 2026 | 93.08M |
| December 31, 2025 | 86.39M |
| September 30, 2025 | 93.10M |
| June 30, 2025 | 81.62M |
| March 31, 2025 | 76.51M |
| December 31, 2024 | 64.94M |
| September 30, 2024 | 59.46M |
| June 30, 2024 | 42.00M |
| March 31, 2024 | 26.22M |
| December 31, 2023 | 28.23M |
| September 30, 2023 | 24.89M |
| June 30, 2023 | 25.95M |
| March 31, 2023 | 30.94M |
| December 31, 2022 | 38.51M |
| September 30, 2022 | 42.14M |
| Date | Value |
|---|---|
| June 30, 2022 | 68.69M |
| March 31, 2022 | 70.20M |
| December 31, 2021 | 79.83M |
| September 30, 2021 | 81.82M |
| June 30, 2021 | 88.14M |
| March 31, 2021 | 92.97M |
| December 31, 2020 | 100.00M |
| September 30, 2020 | 105.96M |
| June 30, 2020 | 12.45M |
| March 31, 2020 | 12.69M |
| December 31, 2019 | 12.60M |
| September 30, 2019 | 11.92M |
| June 30, 2019 | 12.75M |
| March 31, 2019 | 12.35M |
| December 31, 2018 | 7.098M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Xencor, Inc. | 221.73M |
| UroGen Pharma Ltd. | 384.99M |
| MeiraGTx Holdings Plc | 180.67M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.310B |
| Shareholders Equity (Quarterly) | 1.199B |
| Debt to Equity Ratio | 0.0244 |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | -0.02% |